Jichu yixue yu linchuang (Jan 2023)

Progress in application of mesenchymal stem cells in treatment of nephropathy

  • YANG Yunzhao, SHI Meihan, ZHOU Cheng, BAI Xueyuan

DOI
https://doi.org/10.16352/j.issn.1001-6325.2023.01.0030
Journal volume & issue
Vol. 43, no. 1
pp. 30 – 37

Abstract

Read online

Mesenchymal stem cells (MSCs) can reduce inflammation, restore renal injury and maintain immune homeostasis by paracrine various cytokines and regulating immune cells. In preclinical studies, it has been proved that mesenchymal stem cells have obvious therapeutic effects on acute kidney injury, diabetic nephropathy, lupus nephritis and various glomerular diseases in animal models. In clinical studies, mesenchymal stem cells have also been shown to be safe and partially effective. Mesenchymal stem cell therapy has revealed a new model of biotherapy in kidney diseases.

Keywords